Plasminogen activator inhibitor-1 as a link between pathological fibrinolysis and arthritis of Behçet's disease

[1]  I. Haznedaroglu,et al.  Pathological haemostasis and "prothrombotic state" in Behçet's disease. , 2002, Thrombosis research.

[2]  Ş. Kirazlı,et al.  Synovial fluid cytokine levels in Behçet's disease. , 2001, Clinical and experimental rheumatology.

[3]  H. Ronday,et al.  Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor. , 2000, Arthritis and rheumatism.

[4]  B. Dijkmans,et al.  Tranexamic acid, an inhibitor of plasminogen activation, reduces urinary collagen cross-link excretion in both experimental and rheumatoid arthritis. , 1998, British journal of rheumatology.

[5]  A. Bakkaloğlu,et al.  Thrombomodulin, tissue plasminogen activator and plasminogen activator inhibitor-1 in Henoch-Schönlein purpura. , 1998, Clinical and experimental rheumatology.

[6]  G. Hughes,et al.  The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome. , 1997, British journal of rheumatology.

[7]  S. Kiraz,et al.  Characteristics of peripheral arthritis in Behçet's disease. , 1997, The New Zealand medical journal.

[8]  H. Ronday,et al.  Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis. , 1997, British journal of rheumatology.

[9]  J. Marenco,et al.  Thrombolytic therapy in pulmonary embolism of Behçet's disease. , 1996, Acta haematologica.

[10]  J. Oleksyszyn,et al.  Plasminogen modulation of IL-1-stimulated degradation in bovine and human articular cartilage explants. The role of the endogenous inhibitors: PAI-1, alpha 2-antiplasmin, alpha 1-PI, alpha 2-macroglobulin and TIMP. , 1996, Inflammation research : official journal of the European Histamine Research Society ... [et al.].

[11]  D. Tatakis.  Interleukin-1 and bone metabolism: a review. , 1993, Journal of periodontology.

[12]  J. Reynolds,et al.  The Role of Plasmhogen Activators in the Regulation of Connective Tissue Metalloproteinases a , 1992 .

[13]  C. Hack,et al.  Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases. , 1992, Arthritis and rheumatism.

[14]  D. Alarcón-Segovia,et al.  Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosus , 1991, American journal of hematology.

[15]  G. Mundy,et al.  Effects of interleukin-1 on bone turnover in normal mice. , 1989, Endocrinology.

[16]  A. Mauviel,et al.  Transforming growth factor β stimulates collagen and glycosaminoglycan biosynthesis in cultured rabbit articular chondrocytes , 1988, FEBS letters.

[17]  E. Kruithof.  Plasminogen activator inhibitor type 1: Biochemical, biological and clinical aspects , 1988 .

[18]  B. Beutler,et al.  Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts , 1985, The Journal of experimental medicine.

[19]  A. Takeuchi,et al.  Radiographic abnormalities in patients with Behçet's disease. , 1984, Clinical and experimental rheumatology.

[20]  P. Dieppe,et al.  Arthritis in Behcet's syndrome. , 1983, The British journal of radiology.

[21]  H. Behcet.  UBER REZIDIVERENDE APHTHOSE DURCH EIN VIRUS VERURSACHTE GESCHWURE AM MUND, AM AUGE UND AN DEN GENITALIEN , 1937 .